연구동향 분석

Original Article : Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study

( Gi Hyun Kim ) ( Jung Wha Chung ) Jong-Ho Lee ( Kyeong Sam Ok ) ( Eun Sun Jang ) ( Jaihwan Kim ) ( Cheol Min Shin ) ( Young Soo Park ) ( Jin Hyeok Hwang ) ( Sook Hyang Jeong ) ( Nayoung Kim ) ( Dong Ho Lee ) ( Jin Wook Kim ) 2015년

논문상세정보
인용/피인용
' Original Article : Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • metabolic syndrome
  • non alcoholic fatty liver disease
  • propensity score
  • vitamin e
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
465 0

0.0%

' Original Article : Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study' 의 참고문헌

  • Vitamin E and nonalcoholic fatty liver disease
    Pacana T Curr Opin Clin Nutr Metab Care 15 : 641 ~ 648 [2012]
  • Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
    Hoofnagle JH Aliment Pharmacol Ther 38 : 134 ~ 143 [2013]
  • Therapy of NAFLD:antioxidants and cytoprotective agents
    Chang CY J Clin Gastroenterol 40 (1) : S51 ~ S60 [2006]
  • The natural history of nonalcoholic fatty liver disease:a population-based cohort study
    Adams LA Gastroenterology 129 : 113 ~ 121 [2005]
  • The molecular basis for oxidative stress-induced insulin resistance
    Evans JL Antioxid Redox Signal 7 : 1040 ~ 1052 [2005]
  • The epidemiology of nonalcoholic fatty liver disease : a global perspective
    Lazo M Semin Liver Dis 28 : 339 ~ 350 [2008]
  • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
    Chalasani N Gastroenterology 142 : 1592 ~ 1609 [2012]
  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani N Hepatology 55 : 2005 ~ 2023 [2012]
  • The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD
    Angulo P Hepatology 45 : 846 ~ 854 [2007]
  • Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    Vernon G Aliment Pharmacol Ther 34 : 274 ~ 285 [2011]
  • Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
    Dunn W Am J Gastroenterol 103 : 2263 ~ 2271 [2008]
  • Seoul National University Bundang Hospital’s Electronic System for Total Care
    Yoo S Healthc Inform Res 18 : 145 ~ 152 [2012]
  • Randomizedcontrolled trial testing the effects of weight loss on nonalcoholicsteatohepatitis
    Promrat K Hepatology 51 : 121 ~ 129 [2010]
  • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    D’Agostino RB Statistics in Medicine 17 : 2265 ~ 2281 [1998]
  • Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis
    Phung N Int J Mol Med 24 : 171 ~ 180 [2009]
  • Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    Sanyal AJ N Engl J Med 362 : 1675 ~ 1685 [2010]
  • Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis : an updated meta-analysis
    Lin ZH Hepatology 53 : 726 ~ 736 [2011]
  • Oxidative stress and insulin resistance : the coronary artery risk development in young adults study
    Park K Diabetes Care 32 : 1302 ~ 1307 [2009]
  • Orlistat for overweight subjects with nonalcoholic steatohepatitis:a randomized, prospective trial
    Harrison SA Hepatology 49 : 80 ~ 86 [2009]
  • Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association
    Pagano G Hepatology 35 : 367 ~ 372 [2002]
  • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
    Marchesini G Hepatology 37 : 917 ~ 923 [2003]
  • Nonalcoholic fatty liver disease : predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
    Dixon JB Gastroenterology 121 : 91 ~ 100 [2001]
  • NASH and insulin resistance : insulin hypersecretion and specific association with the insulin resistance syndrome
    Chitturi S Hepatology 35 : 373 ~ 379 [2002]
  • Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine
    Lim YS Gastroenterology 147 : 152 ~ 161 [2014]
  • Molecular mediators of hepatic steatosis and liver injury
    Browning JD J Clin Invest 114 : 147 ~ 152 [2004]
  • Metabolic syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation
    Alberti KG Diabet Med 23 : 469 ~ 480 [2006]
  • Metabolic syndrome isassociated with greater histologic severity, higher carbohydrate,and lower fat diet in patients with NAFLD
    Kang H Am J Gastroenterol 101 : 2247 ~ 2253 [2006]
  • Long-term follow-up of patients with NAFLD and elevated liver enzymes
    Ekstedt M Hepatology 44 : 865 ~ 873 [2006]
  • Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
    Hosaka T Hepatology 58 : 98 ~ 107 [2013]
  • KASL clinical practice guidelines : management of nonalcoholic fatty liver disease
    Korean Association for the Study of the Liver( Clin Mol Hepatol 19 : 325 ~ 348 [2013]
  • Is vitamin E beneficial in chronic liver disease?
    Hickman I Hepatology 46 : 288 ~ 290 [2007]
  • Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
    Videla LA Trends Mol Med 12 : 555 ~ 558 [2006]
  • Identification of individuals with insulin resistance using routine clinical measurements
    Stern SE Diabetes 54 : 333 ~ 339 [2005]
  • Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region : executive summary
    Farrell GC J Gastroenterol Hepatol 22 : 775 ~ 777 [2007]
  • Features, diagnosis, and treatment of nonalcoholic fatty liver disease
    Torres DM Clin Gastroenterol Hepatol 10 : 837 ~ 858 [2012]
  • Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
    Lavine JE JAMA 305 : 1659 ~ 1668 [2011]
  • Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease
    Polyzos SA J Renin Angiotensin Aldosterone Syst 12 : 498 ~ 503 [2011]
  • Disease progression of non-alcoholic fatty liver disease : a prospective study with paired liver biopsies at 3 years
    Wong VW Gut 59 : 969 ~ 974 [2010]
  • Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
    Grundy SM Circulation 109 : 433 ~ 438 [2004]